Thai P. Hong, Paul Gow, Michael Fink, Anouk Dev, Stuart Roberts, Amanda Nicoll, John Lubel, Ian Kronborg, Niranjan Arachchi, Marno Ryan, William Kemp, Virginia Knight, Helen Farrugia, Vicky Thursfield, Paul Desmond, Alexander J. Thompson, Sally Bell – 5 October 2015 – Hepatocellular carcinoma (HCC) incidence is rising rapidly in many developed countries.
Tatiana Hildebrand, Nadine Pannicke, Alexander Dechene, Daniel N. Gotthardt, Gabriele Kirchner, Florian P. Reiter, Martina Sterneck, Kerstin Herzer, Henrike Lenzen, Christian Rupp, Hannelore Barg‐Hock, Philipp Leuw, Andreas Teufel, Vincent Zimmer, Frank Lammert, Christoph Sarrazin, Ulrich Spengler, Christian Rust, Michael P. Manns, Christian P. Strassburg, Christoph Schramm, Tobias J.
Zhi Li, Jiexiong Feng, Xiaoyi Sun – 5 October 2015
Babak Banan, Zhenyu Xiao, Rao Watson, Min Xu, Jianluo Jia, Gundumi A. Upadhya, Thalachallour Mohanakumar, Yiing Lin, William Chapman – 5 October 2015 – Normothermic extracorporeal liver perfusion (NELP) can decrease ischemia/reperfusion injury to the greatest degree when cold ischemia time is minimized. Warm perfusion of cold‐stored livers results in hepatocellular damage, sinusoidal endothelial cell (SEC) dysfunction, and Kupffer cell activation. However, the logistics of organ procurement mandates a period of cold preservation before NELP.
Salvatore Sollima, Laura Milazzo, Alessandro Torre, Elisa Calvi, Enrico Regalia, Spinello Antinori – 5 October 2015
Kenneth Washburn, Ann Harper, Timothy Baker, Erick Edwards – 5 October 2015 – The Share 35 policy was implemented June 2013. We sought to evaluate liver offer acceptance patterns of centers under this policy. We compared three 1‐year eras (1, 2, and 3) before and 1 era (4) after the implementation date of the Share 35 policy (June 18, 2013). We evaluated all offers for liver‐only recipients including only those offers for livers that were ultimately transplanted. Logistic regression was used to develop a liver acceptance model.
Teruyuki Miyazaki, Shintaro Yamazaki, Tadatoshi Takayama, Masamichi Moriguchi, Tokio Higaki, Tsutomu Kashimura, Hiroaki Nakazawa, Shyunichi Matsuoka, Mitsuhiko Moriyama, Masatoshi Makuuchi – 5 October 2015
Ian A. Rowe, Damien C. Tully, Matthew J. Armstrong, Richard Parker, Kathy Guo, Darren Barton, Gene D. Morse, Charles S. Venuto, Colin B. Ogilvie, Ditte L. Hedegaard, Jeffrey F. McKelvy, Flossie Wong‐Staal, Todd M. Allen, Peter Balfe, Jane A. McKeating, David J. Mutimer – 5 October 2015 – Hepatitis C virus (HCV) entry inhibitors have been hypothesized to prevent infection of the liver after transplantation. ITX5061 is a scavenger receptor class B type I antagonist that blocks HCV entry and infection in vitro.
Itxarone Bilbao, Magda Guilera – 5 October 2015
Harshad Devarbhavi, Sujata Raj, Venu H. Aradya, Vijaykumar T. Rangegowda, Girish P. Veeranna, Rajvir Singh, Vishnuvardan Reddy, Mallikarjun Patil – 5 October 2015 – The liver and skin are the organs most commonly involved in serious adverse drug reactions. Rarely a drug reaction can affect both organs concurrently. The association of drug‐induced liver injury (DILI) and Stevens‐Johnson syndrome (SJS) or toxic epidermal necrosis (TEN) is even rarer and not well studied.